These common genetic variants have been correlated with higher α-synuclein expression in vitro58 or with elevated brain or peripheral levels of α-synuclein in vivo57,59 and it is a biologically plausible hypothesis that these same mechanisms could impact the heterogeneity that is observed in PD. The gene discussed is SNCA; the disease is Parkinson disease.